Advertisement
Advertisement
U.S. Markets close in 9 mins
Advertisement
Advertisement
Advertisement
Advertisement

EHAVE, Inc. (EHVVF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00800.0000 (0.00%)
As of 03:22PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0080
Open0.0067
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0067 - 0.0080
52 Week Range0.0055 - 0.1000
Volume42,881
Avg. Volume562,769
Market Cap805,024
Beta (5Y Monthly)2.59
PE Ratio (TTM)N/A
EPS (TTM)-0.1100
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Ehave Announces MetaHealthU Will Enter The Market With A Focus On HPPD

    MIAMI, April 19, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today its MetaHealthU mobile application platform will focus on determining the cause and finding a possible cure for hallucinogen-persisting perception disorder (HPPD). Ehave has pioneered HPPD research efforts by launching a series of studies through its partnership with the University of Melbourne to gather data and bio-markers to target the

  • GlobeNewswire

    Mycotopia Therapies Inc. To Enter $13 Billion Medicinal Mushroom Market With HAVN Life Sciences' Biopharmaceuticals And Ei.Ventures MANA Products

    Mycotopia Therapies and Ei.Ventures are moving forward with plans to form PSLY.COM; HAVN Life Sciences' functional mushrooms will be used in PSLY.COM’s MANA products, its line of whole-plant based medicinal mushroom nutraceuticals being developed for the consumer marketMIAMI, March 21, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics, announced today plans to enter

  • GlobeNewswire

    Ehave Continues Expansion Of KetaDASH Mobile Psychedelic Service By Providing Licensed Psychotherapists And Registered Nurses

    Agreement with Heally adds doctors, licensed psychotherapists and registered nurses to the KetaDASH platformWith the opening of KetaDASH, Ehave builds momentum for the psychedelic renaissance in the mental health fieldBoth the KetaDASH patient and nurse connect to a psychotherapist via Heally’s telehealth portal for each treatment session MIAMI, March 03, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today

Advertisement
Advertisement